A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

Researchers at Medicine have uncovered a new mechanism that controls a special group of immune cells known as regulatory ...

Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

One woman and two men with severe autoimmune conditions have gone into remission after being treated with bioengineered and ...

Northwestern Medicine scientists have discovered a new mechanism that controls a specialized group of T-cells, known as ...

The researchers conducted a study on mice where they directed regulatory T cells to a specific part of the body, increased their number, and activated them to turn off the immune response, a ...

Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells. First cohort at 150 million CAR+T cells already successfully completed ...

In a follow-up study, researchers compared cancer immunotherapy in mice, using either single or double immune responses. And ...

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in ...